Hematology & Oncology Doctors in Washington, PA Accepting Medicare

5 Hematology & Oncology doctors found. Showing 1 - 5

Nitin Kapoor, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 470 Johnson Rd, Suite 10, Washington, PA 15301 Phone: 724-223-3816

Patrick Kane, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 997 N Main St, Suite 2, Washington, PA 15301 Phone: 724-223-3816

Wayne J Pfrimmer, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 997 N Main St, Suite 2, Washington, PA 15301 Phone: 724-223-3816    Fax: 724-223-4079

Jocelyn L Tan, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 997 N Main St, Suite 2, Washington, PA 15301 Phone: 724-223-3816    Fax: 724-223-4079

Alexis M Megaludis, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 997 N Main St, Suite 2, Washington, PA 15301 Phone: 724-223-3816    Fax: 724-223-4079

News Archive

Consumers can trust the quality and value of heart-healthy imported olive oils: Study

Consumers can continue to trust the quality of the imported olive oils they buy in supermarkets throughout the United States, contrary to what the authors of a report funded by a small contingent of domestic olive oil producers would like them to believe.

Ahead of Nov. elections, Hill GOP shelves 'big-ticket' legislation

After a tumultuous week of party infighting and leadership stumbles, congressional Republicans are focused on calming their divided ranks in the months ahead, mostly by touting proposals that have wide backing within the GOP and shelving any big-ticket legislation for the rest of the year. Comprehensive immigration reform, tax reform, tweaks to the federal health care law - bipartisan deals on each are probably dead in the water for the rest of this Congress.

Cell Therapeutics adopts ‘Rights Plan' to protect shareholder interests

Cell Therapeutics, Inc. (CTI) announced today that on December 24, 2009, CTI's Board of Directors (the "Board of Directors") approved and adopted a Shareholder Rights Plan (the "Rights Plan") in which one preferred stock purchase right will be distributed for each common share held as of the close of business on January 7, 2010. Initially, the rights are not exercisable, and are attached to and trade with, all of the shares of CTI's common stock outstanding as of, and issued subsequent to, the record date.

Effects of U.S. cuts to foreign aid would be 'hugely damaging' to American foreign policy

In this New York Times editorial, Carol Giacomo, journalist and member of the newspaper's editorial board, reports on a decline in U.S. foreign aid, writing, "There is a lot of public misunderstanding about foreign aid," adding, "For the sake of national security, this country cannot afford to retreat from the world. Its investment in the State Department and foreign aid helps advance peace and stability by feeding starving people, providing access to doctors and medicines, opening new markets, promoting democracy, curbing nuclear arms and strengthening allies with military and economic assistance".

Read more Medical News

› Verified 3 days ago